Current Rating and Its Significance
MarketsMOJO currently assigns Artemis Medicare Services Ltd a 'Buy' rating, supported by a Mojo Score of 78.0. This score reflects a comprehensive evaluation of the company's quality, valuation, financial trend, and technical indicators. For investors, a 'Buy' rating suggests that the stock is expected to deliver favourable returns relative to its risk profile and sector peers, making it a compelling addition to a diversified portfolio.
Quality Assessment
As of 24 July 2026, Artemis Medicare Services Ltd demonstrates strong operational quality. The company holds a 'good' quality grade, underpinned by its consistent ability to generate positive results. Notably, it has declared positive earnings for nine consecutive quarters, signalling stable and reliable profitability. The operating profit has grown at an impressive annual rate of 59.20%, highlighting robust business expansion and operational efficiency.
Additionally, the company maintains a healthy debt profile, with a Debt to EBITDA ratio of 1.39 times. This low leverage indicates prudent financial management and a strong capacity to service debt obligations, reducing financial risk for shareholders.
Valuation Perspective
From a valuation standpoint, Artemis Medicare Services Ltd is considered attractive. The stock trades at a Price to Book Value of 4.6, which is below the average historical valuations of its sector peers, suggesting it is reasonably priced relative to its net asset value. The company’s Return on Equity (ROE) stands at 11.3%, reflecting efficient utilisation of shareholder capital to generate profits.
Moreover, the Price/Earnings to Growth (PEG) ratio is 3.6, indicating that while the stock is growing, investors should weigh the growth prospects against the current price. The valuation metrics suggest that the stock offers a balanced risk-reward profile, appealing to investors seeking growth at a fair price.
Financial Trend and Performance
The financial trend for Artemis Medicare Services Ltd remains positive as of 24 July 2026. The company has shown consistent growth in key financial parameters, including net sales reaching a quarterly high of ₹279.23 crores and PBDIT (Profit Before Depreciation, Interest, and Taxes) peaking at ₹51.60 crores in the latest quarter. Operating profit to interest coverage ratio is strong at 8.10 times, underscoring the company’s ability to comfortably meet interest expenses from operating earnings.
Stock returns have been encouraging, with a 1-year return of 10.88% and a 6-month return of 19.63%. Over the past three years, Artemis Medicare Services Ltd has consistently outperformed the BSE500 index, delivering steady returns that reflect its operational resilience and market positioning.
Technical Outlook
Technically, the stock is rated as bullish, indicating positive momentum and favourable price trends. Recent price movements show a 1-month gain of 1.58% and a 3-month gain of 14.87%, signalling investor confidence and potential for further appreciation. The stock’s current day change is a slight decline of 0.81%, which is within normal market fluctuations and does not detract from the overall positive technical stance.
Summary for Investors
In summary, Artemis Medicare Services Ltd’s 'Buy' rating reflects a combination of strong operational quality, attractive valuation, positive financial trends, and bullish technical indicators. Investors looking for exposure in the hospital sector may find this stock appealing due to its consistent profitability, manageable debt levels, and growth prospects. The current data as of 24 July 2026 supports a favourable outlook, making it a stock worth considering for medium to long-term investment horizons.
Our latest weekly pick is out! This Large Cap from Steel/Sponge Iron/Pig Iron delivered with target price and complete analysis. See what makes this week's selection special!
- - Latest weekly selection
- - Target price delivered
- - Large Cap special pick
Company Profile and Market Position
Artemis Medicare Services Ltd operates within the hospital sector and is classified as a small-cap company. Despite its size, it has carved out a niche with consistent operational performance and growth. The company’s market capitalisation reflects its emerging status, offering investors potential upside as it scales operations and capitalises on sector growth.
The hospital sector remains a critical component of the healthcare industry, driven by increasing demand for quality medical services and infrastructure. Artemis Medicare Services Ltd’s strong fundamentals position it well to benefit from these sectoral tailwinds.
Risk Considerations
While the overall outlook is positive, investors should consider certain risks. The PEG ratio of 3.6 suggests that the stock’s price already factors in significant growth expectations, which may limit upside if growth slows. Additionally, the Price to Book Value of 4.6, though attractive relative to peers, indicates a premium that requires sustained performance to justify.
Market volatility and sector-specific challenges, such as regulatory changes or shifts in healthcare demand, could also impact the stock’s trajectory. Therefore, investors should monitor quarterly results and sector developments closely.
Conclusion
Artemis Medicare Services Ltd’s current 'Buy' rating by MarketsMOJO, supported by a Mojo Score of 78.0, reflects a well-rounded assessment of its quality, valuation, financial health, and technical momentum. As of 24 July 2026, the company exhibits strong fundamentals and promising growth metrics that make it an attractive option for investors seeking exposure in the hospital sector. The rating signals confidence in the stock’s ability to deliver value, though investors should remain vigilant to market and sector dynamics.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
